Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of acyl-ghrelin on renal sodium reabsorption via ENaC in healthy volunteers
2015-002538-32Phase 2Terminated
- Sponsor
- Medicinsk Forskningsafsnit, Regionshospitalet Holstebro
- Start
- Sep 2015
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of acyl-ghrelin and amiloride (2 arms), sponsored by Medicinsk Forskningsafsnit, Regionshospitalet Holstebro. Primary endpoint: Fractional sodium excretion. Started Sep 2015; status: terminated.
02
Drugs
acyl-ghrelinamiloride
Beyond the preview
Go deeper on 2015-002538-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002538-32.